Russia updates tick-borne encephalitis guidelines for children with new antiviral drugs

Russia’s Health Ministry has released updated guidelines for preventing tick-borne encephalitis in children. The new recommendations shift away from traditional emergency treatments and introduce modern antiviral drugs. Vaccination remains the top priority for protection in high-risk areas. The revised guidelines no longer rely on immunoglobulin as the main emergency treatment for children. Instead, injections are now limited to confirmed cases of tick-borne virus exposure within 72 hours of a bite.

New antiviral options, including Russian-made interferon alpha-2b and immunostimulants, have been added to the protocol. These drugs are available in pill form, eliminating the need for special storage and allowing for immediate use after outdoor activities or a tick bite. The ministry continues to stress routine vaccination as the most effective defence. Alongside immunisation, the guidelines reinforce preventive steps such as wearing protective clothing and performing regular tick checks.

The changes aim to simplify emergency care while maintaining strong protection against the disease. Children in endemic regions are still advised to get vaccinated and follow basic precautions. The updated measures reflect a shift toward more practical and accessible treatments.